In Brief: Guidant Ventak AV II
This article was originally published in The Gray Sheet
Executive Summary
Guidant Ventak AV II: Firm's second-generation automatic implantable cardioverter defibrillator/dual-chamber pacing system for the treatment of arrhythmias will be available in the U.S. by mid-1998, Guidant says. The firm gained FDA sign-off on a premarket approval application supplement for the 73 cc, 136-gram system in mid-December. The device incorporates the company's Endotak lead and Triad three-electrode energy defibrillation system, and offers detection and diagnostic enhancements through its Quick Start and Auto Interrogate programming features, the company says. Guidant will discontinue availability of the Ventak AV once the AV II model reaches the market...